Susan Rotzinger

Title: The Innovative Contributions of Susan Rotzinger

Introduction

Susan Rotzinger is a notable inventor based in Etobicoke, Canada. She has made significant contributions to the field of neurobiology through her innovative research and patents. Her work focuses on the development of biologically active neuropeptides that have important implications for neuronal communication and various neuropathologies.

Latest Patents

Susan holds a patent for her invention titled "Teneurin c-terminal associated peptides (TCAP) and uses thereof." This invention provides a novel family of biologically active neuropeptides and the nucleic acid molecules coding for them. The peptides are derived from the C-terminus of the teneurin family peptides (Ten M1-4). These novel peptides, referred to as teneurin C-terminal associated peptides (TCAPs), are active in neuronal communication and are implicated in a number of neuropathologies. They are particularly useful in modulating stress responses and anxiety, as well as in the treatment of cancer. Susan's patent represents a significant advancement in the understanding and potential treatment of these conditions.

Career Highlights

Throughout her career, Susan has demonstrated a commitment to advancing scientific knowledge and innovation. Her research has led to the development of groundbreaking therapies that address critical health issues. With her expertise in neurobiology, she has positioned herself as a leader in her field.

Collaborations

Susan has collaborated with notable professionals in her field, including David Lovejoy and R. Bradley Chewpoy. These collaborations have enriched her research and contributed to the success of her innovative projects.

Conclusion

Susan Rotzinger's contributions to the field of neurobiology through her patent on teneurin C-terminal associated peptides highlight her role as an influential inventor. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.